LDN-27219 Secrets

Usage of drug for that therapy of bronchial asthma as monotherapy with out a concomitant ICS is contraindicated; use only as additional therapy for clients with asthma who are now using but are inadequately controlled on an ICS; never use drug for sufferers whose asthma is sufficiently managed on re
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15